These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26867256)

  • 1. Hepatitis B and C infection at a large public sector hospital clinic: is it a burden?
    Kurira P; Ndhlovu CE; Gomo ZA
    Cent Afr J Med; 2014; 60(9-12):56-62. PubMed ID: 26867256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care.
    Pappoe F; Hagan CKO; Obiri-Yeboah D; Nsiah P
    BMC Infect Dis; 2019 May; 19(1):380. PubMed ID: 31053100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
    Al-Mughales JA
    J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and hepatitis C virus infections among antiretroviral-naive and -experienced HIV co-infected adults.
    Manyazewal T; Sisay Z; Biadgilign S; Abegaz WE
    J Med Microbiol; 2014 May; 63(Pt 5):742-747. PubMed ID: 24757219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infections of hepatitis B and C with human immunodeficiency virus among adult patients attending human immunodeficiency virus outpatients clinic in Benin City, Nigeria.
    Ojide CK; Kalu EI; Ogbaini-Emevon E; Nwadike VU
    Niger J Clin Pract; 2015; 18(4):516-21. PubMed ID: 25966725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for hepatitis B virus and HIV in patients with chronic hepatitis C: screening performance and outcome.
    Bolther M; Dalgaard LS; Kristensen LH; Tarp BD; Jensen-Fangel S
    Scand J Infect Dis; 2014 Oct; 46(10):686-92. PubMed ID: 25134654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.